Search Results - "Howes O"

Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia.

Authors: McCutcheon, R. Beck, K. D'Ambrosio, E. et al.

Source: Acta Psychiatrica Scandinavica. Jan2018, Vol. 137 Issue 1, p39-46. 8p.

Subjects: Schizophrenia treatment, Drug interactions, Clozapine, Physiological effects of antipsychotic drugs, Pharmacokinetics

Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications.

Authors: Pollak, T. Beck, K. Irani, S. et al.

Source: Psychopharmacology. May2016, Vol. 233 Issue 9, p1605-1621. 17p.

Subjects: Autoantibodies, Central nervous system, Cell surface antigens, Neuron analysis, Mental illness

The practical management of refractory schizophrenia - the Maudsley Treatment REview and Assessment Team service approach.

Authors: Beck, K. McCutcheon, R. Bloomfield, M. A. P. et al.

Source: Acta Psychiatrica Scandinavica. Dec2014, Vol. 130 Issue 6, p427-438. 12p. 3 Charts.

Subjects: Schizophrenia, Antipsychotic agents, Health services administration, Clozapine, Public health, Therapeutics

Practitioner attitudes to clozapine initiation.

Authors: Gee, S. Vergunst, F. Howes, O. et al.

Source: Acta Psychiatrica Scandinavica. Jul2014, Vol. 130 Issue 1, p16-24. 9p.

Subjects: Clozapine, Schizophrenia treatment, Blood testing, Drug prescribing, Drug side effects

Neuropathological changes in the substantia nigra in schizophrenia but not depression.

Authors: Williams, M. Galvin, K. O'Sullivan, B. et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Jun2014, Vol. 264 Issue 4, p285-296. 12p.

Subjects: Schizophrenia treatment, Neurological disorders, Substantia nigra, Physiological effects of dopamine, Cytoarchitectonics, Symptoms

Measuring endogenous changes in serotonergic neurotransmission in humans: a [¹¹C]CUMI-101 PET challenge study.

Authors: Selvaraj, S Turkheimer, F Rosso, L et al.

Source: Molecular Psychiatry. Dec2012, Vol. 17 Issue 12, p1254-1260. 7p. 1 Black and White Photograph, 1 Diagram, 1 Chart, 2 Graphs.

Subjects: Serotoninergic mechanisms, Neural transmission, Neurobehavioral disorders, Positron emission tomography, Citalopram, Antidepressants

Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis.

Authors: Fusar-Poli, P. Howes, O. D. Allen, P. et al.

Source: Molecular Psychiatry. Jan2011, Vol. 16 Issue 1, p67-75. 9p. 1 Chart, 2 Graphs.

Subjects: Schizophrenia, Magnetic resonance imaging, Positron emission tomography, Dopamine, Psychoses

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.

Authors: Demjaha, A. Patel1, M. X. MacCabe, J. H. et al.

Source: Psychological Medicine. Aug2017, Vol. 47 Issue 11, p1981-1989. 9p.

Subjects: Clozapine, Drug therapy for psychoses, Drug therapy for schizophrenia, Antipsychotic agents, Age factors in disease, Demography, Drug resistance, Drugs, Longitudinal method, Multivariate analysis, Patient compliance, Multiple regression analysis, Treatment effectiveness, Disease prevalence, Severity of illness index, Disease duration, Therapeutics

Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.

Authors: Schmidt, A. Antoniades, M. Allen, P. et al.

Source: Psychological Medicine. Jan2017, Vol. 47 Issue 2, p243-254. 12p.

Subjects: Brain, Radiography, Psychoses risk factors, Longitudinal method, Magnetic resonance imaging, Motivation (Psychology), Psychological tests, Psychoses, Prompts (Psychology), Neural pathways, Descriptive statistics

Salience attribution and its relationship to cannabis-induced psychotic symptoms.

Authors: Bloomfield, M. A. P. Mouchlianitis, E. Morgan, C. J. A. et al.

Source: Psychological Medicine. Dec2016, Vol. 46 Issue 16, p3383-3395. 13p.

Subjects: Psychoses risk factors, Cannabis (Genus), Dopamine, Drug addiction, Psychoses, Positron emission tomography

Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.

Authors: Ajnakina, O. Trotta, A. Demjaha, A. et al.

Source: Psychological Medicine. Nov2016, Vol. 46 Issue 15, p3231-3240. 10p.

Subjects: Drug therapy for schizophrenia, Clozapine, Confidence intervals, Drug resistance, Longitudinal method, Odds ratio

Fronto-limbic engagement during moral processing in stimulant users.

Authors: Blackwood, N. Howes, O.

Source: Psychopharmacology. Sep2016, Vol. 233 Issue 17, p3075-3076. 2p.

Subjects: Drug abuse, Personality disorders, Psychopharmacology, Methamphetamine abuse, Moral psychology

Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [¹¹C]DASB PET study.

Authors: Kim, E. Howes, O. D. Park, J. W. et al.

Source: Psychological Medicine. Jan2016, Vol. 46 Issue 2, p357-366. 10p.

Subjects: Blood testing, Body weight, Statistical correlation, Liquid chromatography, Classification of mental disorders, Obsessive-compulsive disorder, Research funding, Statistical sampling, Serotonin, Statistics, Stature, T-test (Statistics), Positron emission tomography, Data analysis, Randomized controlled trials, Severity of illness index, Data analysis software, Descriptive statistics, Citalopram, Therapeutics

Geographic Terms: South Korea

Cannabis use and transition to psychosis in people at ultra-high risk.

Authors: Valmaggia, L. R. Day, F. L. Jones, C. et al.

Source: Psychological Medicine. Sep2014, Vol. 44 Issue 12, p2503-2512. 10p.

Subjects: Psychoses risk factors, Cannabis (Genus), Chi-squared test, Statistical correlation, Longitudinal method, Questionnaires, Substance abuse, T-test (Statistics), Sample size (Statistics), Data analysis software, Descriptive statistics, Kaplan-Meier estimator

Presynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis.

Authors: Bonoldi, I. Howes, O.

Source: CNS Drugs. Jul2014, Vol. 28 Issue 7, p649-663. 15p. 2 Diagrams.

Subjects: Psychiatric treatment, Psychoses, Dopamine receptors, Schizophrenia, Targeted drug delivery, Antipsychotic agents, Neurochemistry

Interpersonal sensitivity in the at-risk mental state for psychosis.

Authors: Masillo, A. Day, F. Laing, J. et al.

Source: Psychological Medicine. Sep2012, Vol. 42 Issue 9, p1835-1845. 11p.

Subjects: Psychological adaptation, Chi-squared test, Comparative studies, Personality, Psychological tests, Psychoses, Questionnaires, Research funding, Scales (Weighing instruments), Self-evaluation, Statistics, U-statistics, Data analysis, Early medical intervention, Data analysis software, Descriptive statistics

Striatal dopamine synthesis capacity in twins discordant for schizophrenia.

Authors: Shotbolt, P. Stokes, P. R. Owens, S. F. et al.

Source: Psychological Medicine. Nov2011, Vol. 41 Issue 11, p2331-2338. 8p.

Subjects: Analysis of variance, Chi-squared test, Dopamine, Schizophrenia, Statistics, Positron emission tomography, Twins, Effect sizes (Statistics), Inter-observer reliability, Case-control method, Data analysis software

A comprehensive review and model of putative prodromal features of bipolar affective disorder.

Authors: Howes, O. D. Lim, S. Theologos, G. et al.

Source: Psychological Medicine. Aug2011, Vol. 41 Issue 8, p1567-1577. 11p.

Subjects: Age factors in disease, Analysis of variance, Medical information storage & retrieval systems, Psychology information storage & retrieval systems, Bipolar disorder, MEDLINE, Online information services, Systematic reviews, Early medical intervention, Symptoms, Prevention

Impaired verbal self-monitoring in individuals at high risk of psychosis.

Authors: Johns, L. C. Allen, P. Valli, I. et al.

Source: Psychological Medicine. Sep2010, Vol. 40 Issue 9, p1433-1442. 10p.

Subjects: Mental health, Psychoses, Self-monitoring (Psychology), Speech, Oral communication, People with schizophrenia

Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia.

Authors: Meaney, A. M. Smith, S. Howes, O. D. et al.

Source: British Journal of Psychiatry. Jun2004, Vol. 184, p503-508. 6p. 1 Chart, 1 Graph.

Subjects: Antipsychotic agents, Psychiatric drugs, Schizophrenia, Psychoses, Pathological psychology, People with schizophrenia, Osteoporosis, Bone diseases, Bone density